HB Portfolio returns to profitability with net profit of ₹145.11 lakh in FY26
HB Portfolio Limited reported a net profit of ₹145.11 lakh for the financial year ended March 31, 2026, reversing the previous year's loss of ₹76.98 lakh. Revenue from operations decreased to ₹1264.76 lakh from ₹1492.31 lakh in FY25. The Board approved the audited financial results on May 29, 2026, and re-appointed M/s. Marv & Associates LLP as Internal Auditor.

*this image is generated using AI for illustrative purposes only.
HB Portfolio Limited returned to profitability in the financial year ended March 31, 2026, reporting a net profit of ₹145.11 lakh compared to a net loss of ₹76.98 lakh in the previous year. Revenue from operations for the year stood at ₹1264.76 lakh, a decrease from ₹1492.31 lakh in FY25. The company’s Board approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, in a meeting held on May 29, 2026.
For the quarter ended March 31, 2026, the company reported a net loss of ₹271.58 lakh. Revenue from operations for the quarter surged to ₹792.71 lakh from ₹208.21 lakh in the corresponding period of the previous year. Total income for the quarter was ₹794.29 lakh. The company’s financial performance was impacted by a net loss on fair value changes of investments amounting to ₹263.28 lakh for the quarter and ₹12.13 lakh for the full year.
Standalone Financial Performance
The standalone financial results highlight a turnaround in the company’s bottom line for the full year, driven by reduced expenses and improved operational metrics. Total expenses for the year decreased to ₹1105.20 lakh from ₹1568.11 lakh in the previous year. Finance costs also reduced significantly to ₹4.33 lakh from ₹25.60 lakh. However, employee benefit expenses increased to ₹200.98 lakh from ₹199.81 lakh.
| Metric | Year Ended 31.03.2026 (₹ in Lakhs) | Year Ended 31.03.2025 (₹ in Lakhs) |
|---|---|---|
| Revenue from Operations | 1264.76 | 1492.31 |
| Total Income | 1267.45 | 1495.93 |
| Total Expenses | 1105.20 | 1568.11 |
| Profit for the Period | 145.11 | (76.98) |
| Basic EPS (Rs.) | 1.35 | (0.72) |
Segment Performance
HB Portfolio operates through two primary business segments: Financial Services and Commodities Trading. The Commodities Trading segment generated revenue of ₹753.41 lakh for the year, while the Financial Services segment contributed ₹511.35 lakh. The Financial Services segment reported a profit before tax and interest of ₹157.07 lakh for the year, while the Commodities Trading segment reported a profit of ₹9.51 lakh.
Consolidated Results and Investments
On a consolidated basis, the company reported a profit of ₹27.94 lakh for the year ended March 31, 2026, compared to a loss of ₹4.31 lakh in the previous year. Total consolidated revenue for the year was ₹2679.63 lakh. The consolidated results include the financials of six subsidiaries and one associate. During the year, the company invested ₹5.92 crore in Infinix9 Hotels & Resorts Private Limited, taking its total investment in the entity to ₹20.92 crore as of March 31, 2026.
Corporate Governance
The Board approved the re-appointment of M/s. Marv & Associates LLP as the Internal Auditor for the financial year 2026-27. The statutory auditors, M/s. N.C. Aggarwal & Co., issued an audit report with an unmodified opinion on the standalone and consolidated financial results. The company also noted that the implementation of new Labour Codes effective May 8, 2026, did not have a material impact on its employee benefits liability.
Historical Stock Returns for HB Portfolio
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.77% | -2.70% | -3.89% | -9.72% | -30.76% | +150.24% |
How will the significant investment in Infinix9 Hotels & Resorts impact HB Portfolio's capital allocation strategy moving forward?
What measures will the company take to stabilize revenue growth following the year-over-year decline in operational income?
Is the surge in quarterly revenue sustainable, or was it driven by one-off factors that might not recur?


































